Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights
Portfolio Pulse from Benzinga Insights
Analysts' ratings for Exact Sciences (NASDAQ:EXAS) have varied over the last quarter, with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has decreased by 12.64%, with a current average target of $75.25. Several analysts have lowered their price targets recently, reflecting a negative shift in sentiment.
July 17, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Analysts' ratings for Exact Sciences have shown a mix of bullish and somewhat bullish sentiments over the last quarter. The average 12-month price target has decreased by 12.64%, with a current average target of $75.25. Several analysts have recently lowered their price targets, indicating a negative shift in sentiment.
The decrease in the average 12-month price target by 12.64% and the recent lowering of price targets by several analysts indicate a negative shift in sentiment towards Exact Sciences. This is likely to have a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100